Evercore ISI Issues Positive Forecast for Danaher (NYSE:DHR) Stock Price

Danaher (NYSE:DHR) had its price target boosted by Evercore ISI from $226.00 to $245.00 in a research report released on Tuesday morning,Benzinga reports. Evercore ISI currently has an outperform rating on the conglomerate’s stock.

Other analysts have also recently issued reports about the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a report on Saturday, September 27th. Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a report on Friday, July 11th. Guggenheim reissued a “buy” rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price target on Danaher in a report on Tuesday, September 2nd. Finally, UBS Group dropped their price target on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $246.74.

Danaher Stock Performance

DHR opened at $208.63 on Tuesday. Danaher has a 12-month low of $171.00 and a 12-month high of $279.41. The stock has a market cap of $149.39 billion, a price-to-earnings ratio of 44.39, a PEG ratio of 3.02 and a beta of 0.77. The business has a 50 day moving average of $200.40 and a 200-day moving average of $197.32. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. During the same period last year, the firm posted $1.72 earnings per share. The business’s revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts expect that Danaher will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 11.20% of the company’s stock.

Hedge Funds Weigh In On Danaher

Hedge funds and other institutional investors have recently modified their holdings of the business. GHP Investment Advisors Inc. boosted its holdings in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares in the last quarter. WFA of San Diego LLC acquired a new stake in shares of Danaher during the 2nd quarter valued at $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher during the 2nd quarter valued at $27,000. Sierra Ocean LLC boosted its holdings in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 76 shares in the last quarter. Finally, Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher during the 1st quarter valued at $31,000. Institutional investors own 79.05% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.